Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rubitecan

Next Previous
X
Search
Drug Profile

Rubitecan

Alternative Names: 9-NC; 9-Nitro-20(S)-camptothecin; 9-Nitro-camptothecin; Partaject Orathecin; Partaject rubitecan; RFS 2000

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator The Stehlin Foundation for Cancer Research
  • Developer SuperGen
  • Class Antineoplastics; Camptothecins; Small molecules
  • Mechanism of Action DNA topoisomerase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - HIV infections; Pancreatic cancer

Highest Development Phases

  • Discontinued Breast cancer; Chronic myelomonocytic leukaemia; Colorectal cancer; HIV infections; Leukaemia; Lung cancer; Myelodysplastic syndromes; Ovarian cancer; Pancreatic cancer; Prostate cancer; Solid tumours

Most Recent Events

  • 26 Apr 2006 Interim results from a US-based phase II clinical trial in patients with primary advanced Pancreatic cancer have been added to the Cancer therapeutic trials section
  • 24 Jan 2006 SuperGen has withdrawn its MAA from the EMEA for rubitecan for the treatment of Pancreatic cancer
  • 20 Jan 2006 Phase-III clinical trials in Pancreatic cancer in European Union (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top